Landscape of genetic alterations of myeloid neoplasms in 305 Chinese cases

Landscape of genetic alterations of myeloid neoplasms in 305 Chinese cases

Objective To analyze the landscape of genetic alterations of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), and myelodysplastic/myeloproliferative neoplasms (MDS/MPN). Methods Second-generation sequencing for common mutant genes was performed in the...

Full description

Bibliographic Details
Main Authors:	GOU Yang, TANG Yongjie, YANG Cheng, PENG Xiangui
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Third Military Medical University 2019-11-01
Series:	Di-san junyi daxue xuebao
Subjects:	acute myeloid leukemia myelodysplastic syndromes myeloproliferative neoplasms myelodysplastic/myeloproliferative neoplasms gene mutation second-generation sequencing signaling pathway
Online Access:	http://aammt.tmmu.edu.cn/Upload/rhtml/201906075.htm

Similar Items

Genetic mutations associated with blood count abnormalities in myeloid neoplasms
by: Chantana Polprasert, et al.
Published: (2022-12-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” Question
by: Wilma Barcellini, et al.
Published: (2021-09-01)

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
by: Magdalena M. Brune, et al.
Published: (2021-11-01)

<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
by: Fabio Forghieri, et al.
Published: (2020-11-01)

Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review
by: Lucía Prieto-Torres, et al.
Published: (2023-12-01)

Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53
by: Qian Wang, et al.
Published: (2020-01-01)

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
by: Marion Divoux, et al.
Published: (2020-09-01)

Leucemia mielomonocítica crónica
by: Yamilé Quintero-Sierra, et al.

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies
by: Philipp Ernst, et al.
Published: (2021-02-01)

Chronic Myelomonocytic Leukemia Gold Jubilee
by: Eric Solary, et al.
Published: (2021-07-01)

A model for the functional assessment of elderly with myeloid neoplasms
by: Ana Lúcia Ippolito Carbonell, et al.
Published: (2015-04-01)

Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes: Whoever Seeks Finds
by: Bruno Fattizzo, et al.
Published: (2021-10-01)

Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
by: Alexandra Higgins, et al.
Published: (2020-07-01)

Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study
by: Cristina Bucelli, et al.
Published: (2021-10-01)

Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms
by: Ken Sagou, et al.
Published: (2021-02-01)

Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
by: Hui Zhang, et al.
Published: (2020-05-01)

Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
by: Nicola Andina, et al.
Published: (2022-01-01)

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
by: Michelle Maccarini Barcelos, et al.
Published: (2011-01-01)

Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology
by: Pablo Gargallo, et al.
Published: (2022-04-01)

ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes
by: Xia Wu, et al.
Published: (2020-07-01)

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
by: Mohamed A. Yassin, et al.
Published: (2023-01-01)

The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
by: Jingyi Wang, et al.
Published: (2016-08-01)

The association of bladder myeloid sarcoma and unclassified myelodysplastic/myeloproliferative disease
by: Mehmet Sönmez, et al.
Published: (2009-06-01)

FREQUENCY OF MPL AND JAK2 EXON12 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
by: Sana Latif, et al.
Published: (2020-06-01)

Screening for an underlying myeloproliferative neoplasm in patients with thrombocytosis post-induction chemotherapy for acute myeloid leukemia
by: Stephen E. Langabeer
Published: (2020-01-01)

Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR
by: Felicitas Schulz, et al.
Published: (2023-10-01)

DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?
by: Raquel Ordoñez, et al.
Published: (2019-09-01)

Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
by: Erika Morsia, et al.
Published: (2022-04-01)

What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach
by: Hussein Awada, et al.
Published: (2023-04-01)

The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies
by: Hans Felix Staehle, et al.
Published: (2021-12-01)

Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms
by: Seug Yun Yoon, et al.
Published: (2023-11-01)

Current Understanding of <i>DDX41</i> Mutations in Myeloid Neoplasms
by: Kunhwa Kim, et al.
Published: (2023-01-01)

Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
by: Vanessa Fiorini Furtado, et al.
Published: (2018-10-01)

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
by: Claudia Bănescu, et al.
Published: (2023-03-01)

Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
by: Yammy Yung, et al.
Published: (2021-01-01)

ARMS-PCR Versus AS-PCR to evaluate JAK2V617F mutation in patients with non-CML myeloproliferative neoplasms
by: Nadali F, et al.
Published: (2010-07-01)

Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review
by: Diletta Fontana, et al.
Published: (2023-06-01)

Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging Disease
by: Francesco Mannelli
Published: (2021-01-01)